wehewehe
ʻO CAS No. 312307-38-3, ʻO Vorolazan Intermediate 2 kahi mea nui i ka hana ʻana o Vorolazan, kahi hui me ka waiwai therapeutic kiʻekiʻe i ka mālama ʻana i nā ʻano maʻi maʻi o ke kikowaena.ʻO ka synthesis hoʻomaʻemaʻe o Vorolazan e pili ana i ka hui pū ʻana o Vorolazan Intermediate 2 me nā pūhui ʻē aʻe e hana i kahi huahana i hiki ke hoʻololi i ka mālama ʻana i nā maʻi neurological a me psychiatric.
Loaʻa i ka Vorolazan Intermediate 2 ka maʻemaʻe a me ka kūlike a hoʻokō i nā kūlana koʻikoʻi koʻikoʻi i koi ʻia no ka hana lāʻau lapaʻau.Ke hoʻāʻo nei kā mākou huahana e hōʻoia e hoʻokō a ʻoi aku paha i nā kikoʻī i koi ʻia no Vorolazan synthesis.ʻO ka maikaʻi maikaʻi ʻole o Vorolazan Intermediate 2 he mea hōʻoia i kā mākou kūpaʻa i ka hāʻawi ʻana i kā mākou mea kūʻai aku i nā pūhui kiʻekiʻe loa no kā lākou noiʻi a me nā pono hoʻomohala lāʻau.
E koho iā mākou
Loaʻa iā JDK nā hale hana papa mua a me nā lako hoʻokele maikaʻi, e hōʻoiaʻiʻo ana i ka lako paʻa o nā kikowaena API.Hōʻoia ka hui ʻoihana i ka R&D o ka huahana.E kūʻē i nā mea ʻelua, ke ʻimi nei mākou iā CMO & CDMO ma ka mākeke kūloko a me ka honua.